Effect of amoxycillin/clavulanic acid (augmentin) against polymicrobial Bacteroides fragilis/Escherichia coli infections in the mouse.
Beale
A S
AS
Beecham Pharmaceuticals Research Division, Brockham Park, Betchworth, Surrey, England.
Gisby
J
J
Sutherland
R
R
D019980:Amoxicillin-Potassium Clavulanate Combination / Q000627:therapeutic use*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001442:Bacteroides Infections / Q000188:drug therapy*; D001441:Bacteroides fragilis / Q000302:isolation & purification; D004195:Disease Models, Animal; D004927:Escherichia coli Infections / Q000188:drug therapy*; D051379:Mice
D000900:Anti-Bacterial Agents; D019980:Amoxicillin-Potassium Clavulanate Combination